• N/A
    Market Cap
  • -50.00%
    1-Year Change
  • Software - Infrastructure
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 38
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0002
$0.0002
$0.0002
1-Year Range
$0.0002
$0.0005
$0.0002
Latest Close$0.0002
Change
-$0.0001 (-50.00%)
Volume22,000

Information as of 06/02/2026

Company Profile

N/A
Market Cap
N/A
Net Income
Sector: Technology
Industry: Software - Infrastructure
3557 SW Corporate Parkway, Palm City, FL, United States, 34990
772 283 0020

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

Key Executives

  • Roger K. Cady
  • Javier G. Acosta
  • Charles F. Tarzian

Current Ownership Distribution

  • Other469.4M (75.95%)
  • Insiders148.6M (24.05%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)